While Booth has not indicated his exact reasons for departure, the recently-enacted FDA regulations likely play a role. Because Booth came to the market after the Feb. 15, 2007 date of grandfathering, it’s likely that Room101 would have faced a considerable amount of regulatory costs trying to apply for substantial equivalence.
Austin confirmed that Davidoff of Geneva USA is selling off the remaining Room101 inventory.